AVDLAvadel PharmaceuticalsAVDL info
$10.33info-3.73%24h
Global rank8359
Market cap$927.69M
Change 7d-2.46%
YTD Performance-26.37%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Avadel Pharmaceuticals (AVDL) Stock Overview

    Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

    AVDL Stock Information

    Symbol
    AVDL
    Address
    10 Earlsfort TerraceDublin, 2Ireland
    Founded
    -
    Trading hours
    -
    Website
    https://www.avadel.com
    Country
    🇮🇪 Ireland
    Phone Number
    353 1 901 5201

    Avadel Pharmaceuticals (AVDL) Price Chart

    -
    Value:-

    Avadel Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $10.33
    N/A
    Market Cap
    $927.69M
    N/A
    Shares Outstanding
    89.81M
    N/A
    Employees
    41.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org